The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Genetic variability at the PARK16 locus
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
RAB29 is contained within the PARK16 locus, which is linked to Parkinson's disease.
“RAB29 is contained within the PARK16 locus, which is linked to Parkinson’s disease”
From Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations (2020) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Flagged first, then by citations
Research works printed but not linked: 22
- Lees AJ, Hardy J, Revesz T : Parkinson's disease. Lancet 2009; 373: 2055–2066. · DOI · Paper page
- Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C : The genetics of Parkinson's syndromes: a critical review. Curr Opin Genet Dev 2009; 19: 254–265. · DOI
- Winkler S, Hagenah J, Lincoln S et al: alpha-Synuclein and Parkinson disease susceptibility. Neurology 2007; 69: 1745–1750. · DOI
- Skipper L, Li Y, Bonnard C et al: Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease. Hum Mol Genet 2005; 14: 3549–3556. · DOI
- Di Fonzo A, Wu-Chou YH, Lu CS et al: A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 2006; 7: 133–138. · DOI
- Ross OA, Wu YR, Lee MC et al: Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann Neurol 2008; 64: 88–92. · DOI
- Paisan-Ruiz C, Washecka N, Nath P, Singleton AB, Corder EH : Parkinson's disease and low frequency alleles found together throughout LRRK2. Ann Hum Genet 2009; 73: 391–403. · DOI
- Sidransky E, Nalls MA, Aasly JO et al: Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009; 361: 1651–1661. · DOI · Paper page
- Paisan-Ruiz C : LRRK2 gene variation and its contribution to Parkinson disease. Hum Mutat 2009; 30: 1153–1160. · DOI
- Hardy J, Singleton A : Genomewide association studies and human disease. N Engl J Med 2009; 360: 1759–1768. · DOI · Paper page
- Pankratz N, Wilk JB, Latourelle JC et al: Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 2009; 124: 593–605. · DOI
- Satake W, Nakabayashi Y, Mizuta I et al: Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009; 41: 1303–1307. · DOI
- Simon-Sanchez J, Schulte C, Bras JM et al: Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009; 41: 1308–1312. · DOI · Paper page
- Edwards TL, Scott WK, Almonte C et al: Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 2010; 74: 97–109. · DOI
- Hughes AJ, Daniel SE, Kilford L, Lees AJ : Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181–184. · DOI · Paper page
- Edgar RC : MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004; 32: 1792–1797. · DOI · Paper page
- Greggio E, Cookson MR : Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro 2009; 1: e00002. · DOI
- Cooper AA, Gitler AD, Cashikar A et al: Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006; 313: 324–328. · DOI
- Gitler AD, Bevis BJ, Shorter J et al: The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci USA 2008; 105: 145–150. · DOI
- Bolognin S, Messori L, Zatta P : Metal ion physiopathology in neurodegenerative disorders. Neuromolecular Med 2009; 11: 223–238. · DOI
- Kolisek M, Launay P, Beck A et al: SLC41A1 is a novel mammalian Mg2+ carrier. J Biol Chem 2008; 283: 16235–16247. · DOI
- Evans W, Fung HC, Steele J et al: The tau H2 haplotype is almost exclusively Caucasian in origin. Neurosci Lett 2004; 369: 183–185. · DOI
Cited by
Sorted by citations
Mitochondrial Dysfunction in Parkinson’s Disease
Moon, H. E., & Paek, S. H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.2.103 · Cited by 455
Rivero-Ríos, P., Romo-Lozano, M., Fernández, B., Fdez, E., & Hilfiker, S. (2020) · Cells · doi:10.3390/cells9071719 · Cited by 38
Metadata
- Authors
- Tucci, A., Nalls, M. A., Houlden, H., Revesz, T., Singleton, A. B., Wood, N. W., Hardy, J., & Paisán-Ruiz, C.
- Venue
- European Journal of Human Genetics
- Published
- 2010-08-04
- Volume
- 18
- Issue
- 12
- Pages
- 1356-1359
- ISSN
- 1018-4813
- 1476-5438
- Cited by
- 81
- References
- 1
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
